To access all features of this site, you must enable Javascript. Here are the instructions for enabling Javascript in your web browser.
The François Jacob Institute of Biology brings together five departments and three services
The last two years in scientific news
Find here all the scientific news and highlights about the François Jacob Institute of Biology.
A study published in PNAS highlights a tripartite protein complex that is essential for single-stranded DNA transport during bacterial natural transformation.
TRIGLITEP project aims to overcome a major bottleneck in brain imaging: the biological validation of neuroinflammation biomarkers.
An international study led by Genoscope reveals that mirusviruses, a large group of giant viruses infecting eukaryotic organisms, are far more diverse and widespread than previously known.
Researchers from the DRCM have characterized a new mechanism essential for protecting telomeres. They demonstrated that the protein Rap1 prevents the translocation of the Ku protein thereby avoiding deleterious chromosomal fusions.
In response to the global rise of bacteria that are extremely resistant to antibiotics researchers from the IDMIT Department have developed monoclonal antibodies capable of neutralizing Klebsiella pneumoniae in vitro and in vivo.
In September 2025, the ATLASea research program, led by CEA/Genoscope and CNRS, reached a major milestone: 100 marine species genomes have been sequenced. This achievement highlights the momentum of this national project, launched in 2023, which aims to map the genetic heritage of 4,500 marine eukaryotic species found in French waters.
Researchers at IDMIT, in collaboration with IRBA, have demonstrated in a preclinical model of sexually transmitted monkeypox that the MVA vaccine provides effective protection when administered as pre-exposure prophylaxis but does not confer protection when given post-exposure.
Researchers from IRCM have published findings on the internalization of metallic nanoparticles in cancer cells. These results could be used to target the most aggressive and treatment-resistant tumor cells.
Top page
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.
